Human relevance of pre-clinical studies in stem cell therapy: Systematic review and meta-analysis of large animal models of ischaemic heart disease

Cardiovascular Research

Volumn 91, Issue 4, 2011, Pages 649-658

  Van Der Spoel, Tycho I G ^a   Jansen Of Lorkeers, Sanne J ^a   Agostoni, Pierfrancesco ^a   Van Belle, Eric ^a   Gyongyosi, Mariann ^b   Sluijter, Joost P G ^a,c   Cramer, Maarten J ^a   Doevendans, Pieter A ^a,c   Chamuleau, Steven A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Animal models; Cell therapy; Meta analysis; Myocardial infarction; Stem cells

Indexed keywords

BONE MARROW MONONUCLEAR CELL; CARDIAC STEM CELL; CELL COUNT; CHRONIC DISEASE; CLINICAL RESEARCH; CORONARY ARTERY CIRCUMFLEX BRANCH; EXPERIMENTAL ANIMAL; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; ISCHEMIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL; META ANALYSIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW;

EID: 79958162790     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr113     Document Type: Review

References (75)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117: e25-e146.
2. World Health Organization. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2007. p48-49.
3. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997. (Pubitemid 46835786)
4. Bartunek J, Dimmeler S, Drexler H, Fernández-Avilés F, Galinanes M, Janssens S et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006;27:1338-1340. (Pubitemid 43998109)
5. Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
6. Green S, Higgins JP, Alderson P, Clarke M, Mulrow CD, Oxman AD. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Chichester, UK: John Wiley & Sons, Ltd; 2008.
7. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560. (Pubitemid 37088507)
8. Mansour S, Vanderheyden M, De Bruyne B, Vandekerckhove B, Delrue L, Van Haute I et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol 2006;47:1727-1730.
9. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807-1818.
10. Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA et al. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 2010;14:1064-1070.
11. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4:214-222.
12. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204-1219.
13. Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol 1986;7:349-354. (Pubitemid 16164420)
14. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221. (Pubitemid 44427445)
15. Brunskill SJ, Hyde CJ, Doree CJ, Watt SM, Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009;11:887-896.
16. Zhang S, Sun A, Xu D, Yao K, Huang Z, Jin H et al. Impact of timing on efficacy and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol 2009;32:458-466.
17. Schaefer A, Zwadlo C, Fuchs M, Meyer GP, Lippolt P, Wollert KC et al. Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial2an echocardiographic study. Eur J Echocardiogr 2010;11:165-171.
18. Lafont A, Faxon D. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?. Cardiovasc Res 1998;39:50-59. (Pubitemid 28322379)
19. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006;355:1274-1277. (Pubitemid 44427452)
20. Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH et al. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin Biol Ther 2010;10:667-680.
21. Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet 2002;360: 586. (Pubitemid 35232189)
22. Biondi-Zoccai GGL, Abbate A, Parisi Q, Agostoni P, Burzotta F, Sandroni C et al. Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis. Resuscitation 2003;59:221-224. (Pubitemid 37415064)
23. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York, NY: Oxford University Press; 2000.
24. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 2003;108(Suppl. 1):II247-II252. (Pubitemid 37099963)
25. Brasselet C, Morichetti MC, Messas E, Carrion C, Bissery A, Bruneval P et al. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur Heart J 2005;26: 1551-1556. (Pubitemid 41373498)
26. Chachques JC, Duarte F, Cattadori B, Shafy A, Lila N, Chatellier G et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J Thorac Cardiovasc Surg 2004;128:245-253. (Pubitemid 38969806)
27. Chen SL, Zhu CC, Liu YQ, Tang LJ, Yi L, Yu BJ et al. Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. J Int Med Res 2009;37:68-78.
28. deSilva R, Raval AN, Hadi M, Gildea KM, Bonifacino AC, Yu ZX et al. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J 2008;29:1772-1782.
29. Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH III et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 2009;120:S220-S229.
30. Doyle B, Sorajja P, Hynes B, Kumar AH, Araoz PA, Stalboerger PG et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev 2008;17:941-951.
31. Gavira JJ, Perez-Ilzarbe M, Abizanda G, Garcia-Rodriguez A, Orbe J, Paramo JA et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc Res 2006;71: 744-753. (Pubitemid 44848012)
32. Ghodsizad A, Niehaus M, Kogler G, Martin U, Wernet P, Bara C et al. Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction. Heart 2009;95:27-35.
33. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002;106:I131-I136.
34. Gyongyosi M, Blanco J, Marian T, Tron L, Petnehazy O, Petrasi Z et al. Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008;1:94-103.
35. Hagikura K, Fukuda N, Yokoyama SI, Yuxin L, Kusumi Y, Matsumoto T et al. Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene. Int J Cardiol 2009;142:56-64.
36. Haider HK, Ye L, Jiang S, Ge R, Law PK, Chua T et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 2004;82:539-549. (Pubitemid 39149863)
37. Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 2008;103: 525-536.
38. Hamamoto H, Gorman JH III, Ryan LP, Hinmon R, Martens TP, Schuster MD et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 2009;87:794-801.
39. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008;29:251-259.
40. He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A et al. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 2005;24:1940-1949. (Pubitemid 41641872)
41. Jiang Y, Chen L, Tang Y, Ma G, Shen C, Qi C et al. HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study. Basic Res Cardiol 2010;105:431-442.
42. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009;120:1075-1083.
43. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461-468. (Pubitemid 36158050)
44. Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112:I96-I104. (Pubitemid 41266659)
45. Li CJ, Gao RL, Yang YJ, Hu FH, Yang WX, You SJ et al. Implantation of autologous bone marrow mononuclear cells into ischemic myocardium enhances coronary capillaries and systolic function in miniswine. Chin Med Sci J 2008;23:234-238.
46. Li SR, Qi XY, Hu FL, Zhang JQ, Wang TH, Dang Y et al. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs. Chin Med J (Engl) 2008;121:2403-2409.
47. Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006;70:530-542. (Pubitemid 43732376)
48. Makela J, Ylitalo K, Lehtonen S, Dahlbacka S, Niemela E, Kiviluoma K et al. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site. J Thorac Cardiovasc Surg 2007;134:565-573. (Pubitemid 47301958)
49. Makkar RR, Price MJ, Lill M, Frantzen M, Takizawa K, Kleisli T et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 2005;10:225-233. (Pubitemid 43003333)
50. Memon IA, Sawa Y, Miyagawa S, Taketani S, Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2005;130:646-653. (Pubitemid 41265699)
51. Menard C, Hagege AA, Agbulut O, Barro M, Morichetti MC, Brasselet C et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005;366:1005-1012. (Pubitemid 41323036)
52. Messas E, Bel A, Morichetti MC, Carrion C, Handschumacher MD, Peyrard S et al. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. J Am Coll Cardiol 2006;47:2086-2093.
53. Moelker AD, Baks T, van den Bos EJ, van Geuns RJ, de Feyter PJ, Duncker DJ et al. Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. Eur Heart J 2006;27:3057-3064. (Pubitemid 44950451)
54. Moelker AD, Baks T, Wever KM, Spitskovsky D, Wielopolski PA, van Beusekom HM et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol 2007;42:735-745. (Pubitemid 46533979)
55. Patila T, Ikonen T, Kankuri E, Uutela A, Lommi J, Krogerus L et al. Improved diastolic function after myoblast transplantation in a model of ischemia-infarction. Scand Cardiovasc J 2009;43:100-109.
56. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008;44:486-495. (Pubitemid 351374698)
57. Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 2006;111: 231-239. (Pubitemid 44107562)
58. Qi CM, Ma GS, Liu NF, Shen CX, Chen Z, Liu XJ et al. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model. Chin Med J (Engl) 2008;121:544-550. (Pubitemid 351479636)
59. Qian H, Yang Y, Huang J, Gao R, Dou K, Yang G et al. Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts. J Cell Biochem 2007;102: 64-74. (Pubitemid 47381281)
60. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009;106: 14022-14027.
61. Schneider C, Jaquet K, Geidel S, Rau T, Malisius R, Boczor S et al. Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium. J Am Soc Echocardiogr 2009;22: 1180-1189.
62. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 2008;294:H2002-H2011.
63. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 2009;30:2722-2732.
64. Sheu JJ, Yuen CM, Sun CK, Chang LT, Yen CH, Chiang CH et al. Six-month angiographic study of immediate autologous bone marrow mononuclear cell implantation on acute anterior wall myocardial infarction using a mini-pig model. Int Heart J 2009; 50:221-234.
65. Thompson CA, Reddy VK, Srinivasan A, Houser S, Hayase M, Davila A et al. Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells. J Heart Lung Transplant 2005;24:1385-1392. (Pubitemid 41247826)
66. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132-1140.
67. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28:2667-2677. (Pubitemid 350071533)
68. Wang X, Jameel MN, Li Q, Mansoor A, Qiang X, Swingen C et al. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 2009;120:S238-S246.
69. Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, Dou KF et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol 2009;29:2076-2082.
70. Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B et al. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 2006;13:1564-1568. (Pubitemid 44696121)
71. Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B et al. Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine. Clin Chim Acta 2007;381:114-118. (Pubitemid 46722709)
72. Yi F, Guo WY, Lu AL, Wang HC, Li H, Li WJ et al. Vascular endothelial growth factor expressing mesenchymal stem cells improves cardiac function in chronic myocardial infarction in pigs. Chin Med J (Engl) 2006;119:1664-1668. (Pubitemid 44575628)
73. Yokoyama S, Fukuda N, Li Y, Hagikura K, Takayama T, Kunimoto S et al. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol 2006;40:24-34. (Pubitemid 43012114)
74. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 2007;115: 1866-1875. (Pubitemid 46598900)
75. Zhang S, Ge J, Zhao L, Qian J, Huang Z, Shen L et al. Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells 2007;25:1195-1203. (Pubitemid 46684879)